<http://webisa.webdatacommons.org/212616324>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/438266346>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/212616324> .
<http://webisa.webdatacommons.org/212616324>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<clinicaltrials.gov> .
<http://webisa.webdatacommons.org/prov/139978228>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/212616324> .
<http://webisa.webdatacommons.org/212616324>	<http://www.w3.org/ns/prov#value>	"NYHA class II-IV heart disease, which includes symptoms such as dyspnea or palpitation and an increasing limitation of exercise capacity or discomfort at rest" .